Copyright
©The Author(s) 2024.
World J Diabetes. Jun 15, 2024; 15(6): 1340-1352
Published online Jun 15, 2024. doi: 10.4239/wjd.v15.i6.1340
Published online Jun 15, 2024. doi: 10.4239/wjd.v15.i6.1340
Figure 3 Gene set enrichment analysis analysis in visceral adipose tissue between control group and duodenal-jejunal bypass group.
A and B: Gene set enrichment analysis (GSEA) analysis of insulin resistance (A) and growth hormone (B) action; C: KEGG map of growth hormone action in adipocytes; D-F: GSEA analysis of JAK-STAT signaling pathway (D), MAPK signaling pathway (E), and adipocytokine signaling pathway (F). DJB vs control group. DJB: Duodenal-jejunal bypass; SAT: Subcutaneous adipose tissue; VAT: Visceral adipose tissue.
- Citation: Liu ZT, Yang GW, Zhao X, Dong SH, Jiao Y, Ge Z, Yu A, Zhang XQ, Xu XZ, Cheng ZQ, Zhang X, Wang KX. Growth hormone improves insulin resistance in visceral adipose tissue after duodenal-jejunal bypass by regulating adiponectin secretion. World J Diabetes 2024; 15(6): 1340-1352
- URL: https://www.wjgnet.com/1948-9358/full/v15/i6/1340.htm
- DOI: https://dx.doi.org/10.4239/wjd.v15.i6.1340